Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ROIV

Roivant Sciences Ltd.

CIK 0001635088 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$36.30
↓ 0.54 (-1.47%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$26.22B
P/E Ratio
-98.48
EPS
-0.43
Dividend Yield
Not covered
52W Position
94%
Beta
1.06

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
5.33
P/S
3,481.19
EV/Revenue
3,315.44
ROE
-5.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 94%
$11.54$37.97

Latest Financials

2026-03-31 FY
Revenue
$8.26M
Net Income
-$299.77M
Total Assets
$5.71B
Free Cash Flow
-$758.56M

Recent news